Episode Details
Back to Episodes299. Guidelines: 2021 ESC Cardiovascular Prevention – Question #25 with Dr. Eugene Yang
Description
The following question refers to Section 3.2 of the 2021 ESC CV Prevention Guidelines. The question is asked by student Dr. Hirsh Elhence, answered first by Mayo Clinic Fellow Dr. Teodora Donisan, and then by expert faculty Dr. Eugene Yang.
Dr. Yang is professor of medicine of the University of Washington where he is medical director of the Eastside Specialty Center and the co-Director of the Cardiovascular Wellness and Prevention Program. Dr. Yang is former Governor of the ACC Washington Chapter and chair of the ACC Prevention of CVD Section.
The CardioNerds Decipher The Guidelines Series for the 2021 ESC CV Prevention Guidelines represents a collaboration with the ACC Prevention of CVD Section, the National Lipid Association, and Preventive Cardiovascular Nurses Association.
|
Please choose the CORRECT statement from the ones below. |
|
|
A |
CAC scoring can be considered to improve ASCVD risk classification around treatment decision thresholds. |
|
B |
Patients with type 1 or type 2 diabetes are considered very high CV risk, regardless of comorbidities and other risk factors. |
|
C |
CKD does not increase the cardiovascular risk in the absence of other risk factors. |
|
D |
Men and women older than 65 years old are at high cardiovascular risk. |
|
Explanation |
Option A is correct. Coronary artery calcium (CA Listen NowLove PodBriefly?If you like Podbriefly.com, please consider donating to support the ongoing development. Support Us |